PROFERVIA Trademark

Trademark Overview

On Wednesday, March 6, 2019, a trademark application was filed for PROFERVIA with the United States Patent and Trademark Office. The USPTO has given the PROFERVIA trademark a serial number of 88328637. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 22, 2023. This trademark is owned by Aisa Pharma, Inc.. The PROFERVIA trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
profervia

General Information

Serial Number88328637
Word MarkPROFERVIA
Filing DateWednesday, March 6, 2019
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 22, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 25, 2019
Primary Code005
First Use Anywhere DateWednesday, June 16, 2021
First Use In Commerce DateWednesday, June 16, 2021

Trademark Owner History

Party NameAisa Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02108
Party NameAisa Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02108

Trademark Events

Event DateEvent Description
Friday, November 24, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, November 22, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, November 22, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Saturday, August 5, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, August 5, 2023FINAL REFUSAL E-MAILED
Saturday, August 5, 2023SU - FINAL REFUSAL - WRITTEN
Thursday, July 6, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, March 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 29, 2023ASSIGNED TO LIE
Wednesday, January 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 3, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 3, 2022NON-FINAL ACTION E-MAILED
Monday, October 3, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, September 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 6, 2022USE AMENDMENT FILED
Tuesday, September 6, 2022TEAS STATEMENT OF USE RECEIVED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2022SOU EXTENSION 5 GRANTED
Monday, February 28, 2022SOU EXTENSION 5 FILED
Tuesday, March 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 25, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 23, 2021SOU EXTENSION 4 GRANTED
Monday, August 23, 2021SOU EXTENSION 4 FILED
Monday, August 23, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, January 27, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 25, 2021SOU EXTENSION 3 GRANTED
Monday, January 25, 2021SOU EXTENSION 3 FILED
Monday, January 25, 2021SOU TEAS EXTENSION RECEIVED
Thursday, September 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 1, 2020SOU EXTENSION 2 GRANTED
Tuesday, September 1, 2020SOU EXTENSION 2 FILED
Tuesday, September 1, 2020SOU TEAS EXTENSION RECEIVED
Friday, August 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 3, 2020SOU EXTENSION 1 FILED
Friday, August 7, 2020NOTICE OF REVIVAL - E-MAILED
Thursday, August 6, 2020SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, August 6, 2020PETITION TO REVIVE-GRANTED
Thursday, August 6, 2020TEAS PETITION TO REVIVE RECEIVED
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 30, 2019ASSIGNED TO LIE
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 15, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2019EXAMINERS AMENDMENT E-MAILED
Wednesday, May 15, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 15, 2019ASSIGNED TO EXAMINER
Monday, March 25, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 9, 2019NEW APPLICATION ENTERED

Related Keywords

profervia active release ingredients wide pharmaceuticals variety controlled provide agents delivery